Summary

Market Overview:

The global cognitive and memory enhancer drugs market size reached US$ 5,552.16 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 7,693.88 Million by 2028, exhibiting a growth rate (CAGR) of 5.80% during 2023-2028. The growing prevalence of cognitive disorders, increasing research and development (R&D) activities to explore new compounds and formulations, and introduction of novel drugs and innovative delivery methods represent some of the key factors driving the market.

Cognitive and memory enhancer drugs, also known as nootropics or smart drugs, aim to improve cognitive function like memory, attention, creativity, and overall mental performance. These drugs are designed to enhance brain activity and promote better cognitive abilities. They are available by prescription for specific medical conditions and can be purchased over the counter (OTC) or online as dietary supplements. They enhance alertness and focus by increasing the release of certain neurotransmitters in the brain. They also boost acetylcholine levels, which is important for memory and learning. They act as antioxidants or anti-inflammatory agents, protecting the brain from damage and promoting optimal brain function. They can also promote clearer thinking and improve cognitive processing speed and lead to better decision-making abilities. They assist in improving short-term and long-term memory, which makes it easier to recall and retain information. They also aid in enhancing academic or work performance by increasing productivity, efficiency, and cognitive abilities.

Cognitive and Memory Enhancer Drugs Market Trends:
At present, the rising prevalence of cognitive disorders, such as Alzheimer's disease, dementia, and attention deficit hyperactivity disorder (ADHD), represents one of the key factors supporting the growth of the market. Besides this, people are becoming more proactive in taking care of their brain health and seeking ways to enhance their cognitive abilities, which is catalyzing the demand for cognitive and memory enhancer drugs. Moreover, increasing research and development (R&D) activities to explore new compounds and formulations that can enhance cognitive functions and memory is propelling the growth of the market. In line with this, the development of novel drugs and innovative delivery methods is expanding the range of options available to consumers, which is strengthening the growth of the market. In addition, the growing demand for drugs that can alleviate age-related cognitive decline and memory loss due to the rising elderly population is offering a favorable market outlook. Apart from this, the increasing adoption of cognitive and memory enhancer drugs among students and professionals seeking improved academic and professional performance is creating lucrative growth opportunities for industry investors. Additionally, the wide availability of cognitive and memory enhancer drugs through online and offline distribution channels is strengthening the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global cognitive and memory enhancer drugs market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on product and application.

Product Insights:

Aricept
Exelon
Namenda
Razadyne
Provigil
Ritalin
Adderall
Others

The report has provided a detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the type. This includes Aricept, Exelon, Namenda, Razadyne, Provigil, Ritalin, Adderall, and others. According to the report, Aricept represented the largest segment.

Application Insights:

Disease Treatment
Athletic Performance
Academic Performance
Others

A detailed breakup and analysis of the cognitive and memory enhancer drugs market based on the application has also been provided in the report. This includes disease treatment, athletic performance, academic performance, and others. According to the report, disease treatment accounted for the largest market share.

Regional Insights:

North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for cognitive and memory enhancer drugs. Some of the factors driving the North America cognitive and memory enhancer drugs market included the growing elderly population, increasing need to enhance focus, memory, and overall cognitive abilities, development of novel drugs, etc.

Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global cognitive and memory enhancer drugs market. Detailed profiles of all major companies have been provided. Some of the companies covered include AbbVie Inc., Biogen Inc., Eisai Co Ltd., Novartis AG, Takeda Pharmaceutical Company Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global cognitive and memory enhancer drugs market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global cognitive and memory enhancer drugs market?
What is the impact of each driver, restraint, and opportunity on the global cognitive and memory enhancer drugs market?
What are the key regional markets?
Which countries represent the most attractive cognitive and memory enhancer drugs market?
What is the breakup of the market based on the product?
Which is the most attractive product in the cognitive and memory enhancer drugs market?
What is the breakup of the market based on the application?
Which is the most attractive application in the cognitive and memory enhancer drugs market?
What is the competitive structure of the global cognitive and memory enhancer drugs market?
Who are the key players/companies in the global cognitive and memory enhancer drugs market?

ページTOPに戻る

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cognitive and Memory Enhancer Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Aricept
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Exelon
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Namenda
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Razadyne
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Provigil
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Ritalin
6.6.1 Market Trends
6.6.2 Market Forecast
6.7 Adderall
6.7.1 Market Trends
6.7.2 Market Forecast
6.8 Others
6.8.1 Market Trends
6.8.2 Market Forecast
7 Market Breakup by Application
7.1 Disease Treatment
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Athletic Performance
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Academic Performance
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Region
8.1 North America
8.1.1 United States
8.1.1.1 Market Trends
8.1.1.2 Market Forecast
8.1.2 Canada
8.1.2.1 Market Trends
8.1.2.2 Market Forecast
8.2 Asia-Pacific
8.2.1 China
8.2.1.1 Market Trends
8.2.1.2 Market Forecast
8.2.2 Japan
8.2.2.1 Market Trends
8.2.2.2 Market Forecast
8.2.3 India
8.2.3.1 Market Trends
8.2.3.2 Market Forecast
8.2.4 South Korea
8.2.4.1 Market Trends
8.2.4.2 Market Forecast
8.2.5 Australia
8.2.5.1 Market Trends
8.2.5.2 Market Forecast
8.2.6 Indonesia
8.2.6.1 Market Trends
8.2.6.2 Market Forecast
8.2.7 Others
8.2.7.1 Market Trends
8.2.7.2 Market Forecast
8.3 Europe
8.3.1 Germany
8.3.1.1 Market Trends
8.3.1.2 Market Forecast
8.3.2 France
8.3.2.1 Market Trends
8.3.2.2 Market Forecast
8.3.3 United Kingdom
8.3.3.1 Market Trends
8.3.3.2 Market Forecast
8.3.4 Italy
8.3.4.1 Market Trends
8.3.4.2 Market Forecast
8.3.5 Spain
8.3.5.1 Market Trends
8.3.5.2 Market Forecast
8.3.6 Russia
8.3.6.1 Market Trends
8.3.6.2 Market Forecast
8.3.7 Others
8.3.7.1 Market Trends
8.3.7.2 Market Forecast
8.4 Latin America
8.4.1 Brazil
8.4.1.1 Market Trends
8.4.1.2 Market Forecast
8.4.2 Mexico
8.4.2.1 Market Trends
8.4.2.2 Market Forecast
8.4.3 Others
8.4.3.1 Market Trends
8.4.3.2 Market Forecast
8.5 Middle East and Africa
8.5.1 Market Trends
8.5.2 Market Breakup by Country
8.5.3 Market Forecast
9 Drivers, Restraints, and Opportunities
9.1 Overview
9.2 Drivers
9.3 Restraints
9.4 Opportunities
10 Value Chain Analysis
11 Porters Five Forces Analysis
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Price Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
13.3.1 AbbVie Inc.
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Financials
13.3.1.4 SWOT Analysis
13.3.2 Biogen Inc.
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Financials
13.3.2.4 SWOT Analysis
13.3.3 Eisai Co Ltd.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Financials
13.3.3.4 SWOT Analysis
13.3.4 Novartis AG
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Financials
13.3.4.4 SWOT Analysis
13.3.5 Takeda Pharmaceutical Company Ltd.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Financials
13.3.5.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

List of Figures

Figure 1: Global: Cognitive and Memory Enhancer Drugs Market: Major Drivers and Challenges
Figure 2: Global: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017-2022
Figure 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 4: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Product (in %), 2022
Figure 5: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Application (in %), 2022
Figure 6: Global: Cognitive and Memory Enhancer Drugs Market: Breakup by Region (in %), 2022
Figure 7: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market: Sales Value (in Million US$), 2017 & 2022
Figure 8: Global: Cognitive and Memory Enhancer Drugs (Aricept) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 9: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: Cognitive and Memory Enhancer Drugs (Exelon) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: Cognitive and Memory Enhancer Drugs (Namenda) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: Cognitive and Memory Enhancer Drugs (Razadyne) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: Cognitive and Memory Enhancer Drugs (Provigil) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: Cognitive and Memory Enhancer Drugs (Ritalin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: Cognitive and Memory Enhancer Drugs (Adderall) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: Cognitive and Memory Enhancer Drugs (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: Cognitive and Memory Enhancer Drugs (Disease Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: Cognitive and Memory Enhancer Drugs (Athletic Performance) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: Cognitive and Memory Enhancer Drugs (Academic Performance) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: Cognitive and Memory Enhancer Drugs (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: North America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: North America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: United States: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: United States: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Canada: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Canada: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Asia-Pacific: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: China: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: China: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Japan: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Japan: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: India: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: India: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: South Korea: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: South Korea: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: Australia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: Australia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Indonesia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Indonesia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: Europe: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: Europe: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Germany: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Germany: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: France: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: France: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: United Kingdom: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: United Kingdom: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Italy: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Italy: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Spain: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Spain: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Russia: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Russia: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Latin America: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Latin America: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: Brazil: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: Brazil: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: Mexico: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: Mexico: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Others: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Others: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market: Breakup by Country (in %), 2022
Figure 79: Middle East and Africa: Cognitive and Memory Enhancer Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Global: Cognitive and Memory Enhancer Drugs Industry: Drivers, Restraints, and Opportunities
Figure 81: Global: Cognitive and Memory Enhancer Drugs Industry: Value Chain Analysis
Figure 82: Global: Cognitive and Memory Enhancer Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cognitive and Memory Enhancer Drugs Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Cognitive and Memory Enhancer Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 5: Global: Cognitive and Memory Enhancer Drugs Market: Competitive Structure
Table 6: Global: Cognitive and Memory Enhancer Drugs Market: Key Players